Anti-aging peptide stack
An anti-aging peptide stack pairs Sermorelin, GHK-Cu (topical), and low-dose BPC-157. Gentle, longer-cycle protocol with realistic expectations.
Updated May 7, 2026 · 5 min read
The most-reported anti-aging peptide stack pairs three gentle compounds: Sermorelin for natural-pulse GH support, GHK-Cu (topical) for skin and tissue remodeling, and low-dose BPC-157 for systemic anti-inflammatory and gut support. The stack runs longer cycles than aggressive performance protocols — 16+ weeks or near-continuous with planned breaks — because the goals (sleep quality, tissue maintenance, skin appearance, recovery) express slowly.
This is not the stack for rapid recomposition or training-block performance. The pitch is preservation: keeping function and resilience over time rather than pushing capacity in a defined window.
Why these three specifically
| Compound | Action | Why it fits anti-aging |
|---|---|---|
| Sermorelin | GHRH analog, short half-life | Preserves natural pulsatile GH pattern — low desensitization risk |
| GHK-Cu (topical) | Copper peptide, skin remodeling | Decades of cosmetic safety data, broad anti-inflammatory action |
| BPC-157 (low-dose) | Local angiogenesis, gut and systemic anti-inflammatory | Maintenance support, well-tolerated at low doses |
The unifying logic: each compound is the gentlest version of its category. Sermorelin instead of stronger GH secretagogues. Topical GHK-Cu instead of injected. BPC-157 at maintenance doses instead of recovery-cycle doses. Stacked, they offer broad coverage without the receptor-desensitization or side-effect drift concerns of more aggressive protocols.
Standard protocol
| Compound | Dose | Cadence | Route |
|---|---|---|---|
| Sermorelin | 200 mcg | Once daily, pre-bed | SubQ |
| GHK-Cu (topical) | Per product label | 1-2x daily | Skin (face, hands, areas of concern) |
| BPC-157 | 250 mcg | Daily | SubQ or low-dose oral |
For more on each component, see Sermorelin protocol, GHK-Cu pillar, and BPC-157 dosing protocols.
Why Sermorelin instead of Ipa+CJC
For anti-aging applications, the choice of GH secretagogue matters:
| Property | Sermorelin | Ipa + CJC (no DAC) |
|---|---|---|
| Pulse character | Single GHRH amplification | Synergistic ghrelin + GHRH |
| Magnitude of GH pulse | Modest | Larger |
| Effect on natural rhythm | Preserves it almost entirely | Preserves it but pushes harder |
| Side-effect drift on long runs | Very low | Low to moderate |
| Best for | Long-term, near-continuous use | Discrete 12-16 week cycles |
Sermorelin's smaller pulse is a feature, not a limitation, when the goal is decades-long gentle support rather than a 12-week peak. For discrete cycles aimed at body composition or recovery from a training block, Ipa+CJC is the better choice — see GH stack: Ipa + CJC.
Why topical GHK-Cu
GHK-Cu has been used in cosmetic applications for decades. Topical application has well-characterized skin-level effects (collagen support, anti-inflammatory action, improved skin appearance) with very low systemic exposure. Injected GHK-Cu is also used by some, but the safety database is much smaller, and for an anti-aging protocol the conservative position is topical.
Realistic expectations
Anti-aging stacks ask for patience. A typical reported timeline:
| Window | What users typically report |
|---|---|
| Month 1 | Improved sleep depth, vivid dreams (Sermorelin), no skin changes yet |
| Month 2 | Subjective recovery improvement, slight reduction in joint stiffness |
| Month 3-4 | Visible skin appearance changes (texture, fine lines), consolidated sleep changes |
| Month 6+ | Cumulative effects on resilience and recovery; this is the target window |
Compared to performance stacks, the magnitude per month is smaller. Compounded over months, the cumulative effect is the point. Anyone expecting dramatic 8-week changes is on the wrong protocol.
Cycle structure
The anti-aging stack is one of the few protocols where near-continuous use is defensible:
| Component | Cycling pattern |
|---|---|
| Sermorelin | 16+ weeks on, 4 weeks off — or continuous low-dose pre-bed |
| GHK-Cu (topical) | Continuous OK — decades of cosmetic safety |
| BPC-157 (low-dose) | 12-16 weeks on, 4-8 weeks off |
The "near-continuous" framing matters: even on a long-cycle anti-aging protocol, planned breaks are still useful for end-of-cycle reassessment, bloodwork, and identifying which component is doing what. See off-cycle strategies.
For the broader cycle-length framework, see cycle length by peptide class.
Bloodwork
Annual baseline and check-ins matter more on long-running stacks than on short cycles. Reasonable panel:
- IGF-1, fasting glucose, HbA1c
- Comprehensive metabolic panel
- Lipid panel
- Inflammation markers (hs-CRP)
- For users over 50: PSA (men), age-appropriate screening
The cancer-related cautions for any GH-axis intervention apply. Active or recent malignancy, family history, and elevated IGF-1 are all reasons to talk to a clinician before continuing.
Cost
Anti-aging stacks tend to cost less per month than performance stacks because the doses are lower:
| Component | Approximate monthly cost (research-chem pricing) |
|---|---|
| Sermorelin | $30-80 |
| GHK-Cu topical | $40-100 (cosmetic-grade) |
| BPC-157 low-dose | $25-60 |
Total: roughly $100-250/month at the low-dose anti-aging cadence, vs $300+ for typical performance stacks.
Common mistakes
- Expecting performance-stack magnitudes from gentle compounds
- Adding stronger GH secretagogues "to speed it up" — defeats the natural-pulse design
- Stacking IGF-1 LR3 onto an anti-aging protocol — different risk profile entirely
- Skipping bloodwork on long-running protocols
- Ignoring sleep, training, and stress — these matter more than the peptides